125 related articles for article (PubMed ID: 22958871)
1. RON is not a prognostic marker for resectable pancreatic cancer.
Tactacan CM; Chang DK; Cowley MJ; Humphrey ES; Wu J; Gill AJ; Chou A; Nones K; Grimmond SM; Sutherland RL; Biankin AV; Daly RJ;
BMC Cancer; 2012 Sep; 12():395. PubMed ID: 22958871
[TBL] [Abstract][Full Text] [Related]
2. Tyrosine kinase receptor RON in human pancreatic cancer: expression, function, and validation as a target.
Camp ER; Yang A; Gray MJ; Fan F; Hamilton SR; Evans DB; Hooper AT; Pereira DS; Hicklin DJ; Ellis LM
Cancer; 2007 Mar; 109(6):1030-9. PubMed ID: 17311308
[TBL] [Abstract][Full Text] [Related]
3. The RON receptor tyrosine kinase mediates oncogenic phenotypes in pancreatic cancer cells and is increasingly expressed during pancreatic cancer progression.
Thomas RM; Toney K; Fenoglio-Preiser C; Revelo-Penafiel MP; Hingorani SR; Tuveson DA; Waltz SE; Lowy AM
Cancer Res; 2007 Jul; 67(13):6075-82. PubMed ID: 17616662
[TBL] [Abstract][Full Text] [Related]
4. High expression of S100A11 in pancreatic adenocarcinoma is an unfavorable prognostic marker.
Xiao MB; Jiang F; Ni WK; Chen BY; Lu CH; Li XY; Ni RZ
Med Oncol; 2012 Sep; 29(3):1886-91. PubMed ID: 21912994
[TBL] [Abstract][Full Text] [Related]
5. Tumor COX-2 expression and prognosis of patients with resectable pancreatic cancer.
Matsubayashi H; Infante JR; Winter J; Klein AP; Schulick R; Hruban R; Visvanathan K; Goggins M
Cancer Biol Ther; 2007 Oct; 6(10):1569-75. PubMed ID: 18000398
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological significance and prognostic value of EphA3 and CD133 expression in colorectal carcinoma.
Xi HQ; Zhao P
J Clin Pathol; 2011 Jun; 64(6):498-503. PubMed ID: 21415057
[TBL] [Abstract][Full Text] [Related]
7. The novel tumor angiogenic factor, adrenomedullin-2, predicts survival in pancreatic adenocarcinoma.
Hollander LL; Guo X; Salem RR; Cha CH
J Surg Res; 2015 Aug; 197(2):219-24. PubMed ID: 25982376
[TBL] [Abstract][Full Text] [Related]
8. Decreased RGS6 expression is associated with poor prognosis in pancreatic cancer patients.
Jiang N; Xue R; Bu F; Tong X; Qiang J; Liu R
Int J Clin Exp Pathol; 2014; 7(7):4120-7. PubMed ID: 25120791
[TBL] [Abstract][Full Text] [Related]
9. Comparative characterization of the HGF/Met and MSP/Ron systems in primary pancreatic adenocarcinoma.
Vanderwerff BR; Church KJ; Kawas LH; Harding JW
Cytokine; 2019 Nov; 123():154762. PubMed ID: 31254927
[TBL] [Abstract][Full Text] [Related]
10. Expression of the RON receptor tyrosine kinase and its association with gastric carcinoma versus normal gastric tissues.
Zhou D; Pan G; Zheng C; Zheng J; Yian L; Teng X
BMC Cancer; 2008 Nov; 8():353. PubMed ID: 19040718
[TBL] [Abstract][Full Text] [Related]
11. PROX1 and β-catenin are prognostic markers in pancreatic ductal adenocarcinoma.
Saukkonen K; Hagström J; Mustonen H; Juuti A; Nordling S; Kallio P; Alitalo K; Seppänen H; Haglund C
BMC Cancer; 2016 Jul; 16():472. PubMed ID: 27411302
[TBL] [Abstract][Full Text] [Related]
12. c-Met and RON expression levels in endometrial adenocarcinoma tissue and their relationship with prognosis.
Zhuang XP; Jin WW; Teng XD; Yuan ZZ; Lin QQ; Xu ST
Eur J Gynaecol Oncol; 2015; 36(3):255-9. PubMed ID: 26189249
[TBL] [Abstract][Full Text] [Related]
13. MUC2 but not MUC5 expression correlates with prognosis in radically resected pancreatic cancer patients.
Pantano F; Baldi A; Santini D; Vincenzi B; Borzomati D; Vecchio FM; Castri F; Antinori A; Caraglia M; Magistrelli P; Coppola R; Tonini G
Cancer Biol Ther; 2009 Jun; 8(11):996-9. PubMed ID: 19587537
[TBL] [Abstract][Full Text] [Related]
14. The RON-receptor regulates pancreatic cancer cell migration through phosphorylation-dependent breakdown of the hemidesmosome.
Yu PT; Babicky M; Jaquish D; French R; Marayuma K; Mose E; Niessen S; Hoover H; Shields D; Cheresh D; Cravatt BF; Lowy AM
Int J Cancer; 2012 Oct; 131(8):1744-54. PubMed ID: 22275185
[TBL] [Abstract][Full Text] [Related]
15. Spindle proteins in resected pancreatic head adenocarcinomas: BubR1 is an independent prognostic factor in pancreatobiliary-type tumours.
Gladhaug IP; Westgaard A; Schjølberg AR; Burum-Auensen E; Pomianowska E; Clausen OP
Histopathology; 2010 Feb; 56(3):345-55. PubMed ID: 20459534
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of p21-activated kinase 4 in resected pancreatic cancer.
Park S; Kim JW; Kim H; Kim JW; Kim YJ; Lee KW; Kim JH; Kim JH; Hwang JH; Choi YR; Cho JY; Yoon YS; Han HS
APMIS; 2017 Aug; 125(8):699-707. PubMed ID: 28556956
[TBL] [Abstract][Full Text] [Related]
17. Mucin 16 (cancer antigen 125) expression in human tissues and cell lines and correlation with clinical outcome in adenocarcinomas of the pancreas, esophagus, stomach, and colon.
Streppel MM; Vincent A; Mukherjee R; Campbell NR; Chen SH; Konstantopoulos K; Goggins MG; Van Seuningen I; Maitra A; Montgomery EA
Hum Pathol; 2012 Oct; 43(10):1755-63. PubMed ID: 22542127
[TBL] [Abstract][Full Text] [Related]
18. A PD-L2-based immune marker signature helps to predict survival in resected pancreatic ductal adenocarcinoma.
Zhang Y; Xu J; Hua J; Liu J; Liang C; Meng Q; Wei M; Zhang B; Yu X; Shi S
J Immunother Cancer; 2019 Aug; 7(1):233. PubMed ID: 31464648
[TBL] [Abstract][Full Text] [Related]
19. CD24 and S100A4 expression in resectable pancreatic cancers with earlier disease recurrence and poor survival.
Lee SH; Kim H; Hwang JH; Shin E; Lee HS; Hwang DW; Cho JY; Yoon YS; Han HS; Cha BH
Pancreas; 2014 Apr; 43(3):380-8. PubMed ID: 24622067
[TBL] [Abstract][Full Text] [Related]
20. The prognostic significance of human epidermal growth factor receptor family protein expression in operable pancreatic cancer : HER1-4 protein expression and prognosis in pancreatic cancer.
Li Q; Zhang L; Li X; Yan H; Yang L; Li Y; Li T; Wang J; Cao B
BMC Cancer; 2016 Nov; 16(1):910. PubMed ID: 27871278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
